Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 8.74% vs -4.90% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 59.82% vs -29.21% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 16.28% vs -6.84% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 23.33% vs 7.14% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Vertex Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 8.74% vs -4.90% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 13.33% vs 6.02% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 59.82% vs -29.21% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 128.74% vs -492.44% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 16.28% vs -6.84% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 25.48% vs -16.37% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 23.33% vs 7.14% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -62.63% vs -11.61% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






